通过使用拉曼活性解体性疏水标签对向蛋白质降解的新机制性见解
Craig F Steven1, Manasa Punaha Ravindra2, Martin Lee3
1EaStCHEM School of Chemistry, University of Edinburgh, David Brewster Rd, Edinburgh, EH9 3FJ, UK; Cancer Research UK Scotland Centre (Edinburgh), Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XR, UK.
European journal of medicinal chemistry
|December 12, 2025
概括
研究人员开发了用于向蛋白质降解和同时成像的新型神经水标签 (HyT). 这些新的标签,当与olaparib结合时,在卵巢癌细胞中显示出增强的抗癌活性,并为HyT机制提供了新的见解.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 化学生物学 化学生物学
背景情况:
- 疏水标记 (HyT) 是一种针对蛋白质降解的技术.
- 开发更高效的HyT系统对于研究降解机制和改善治疗应用至关重要.
- 了解HyT诱导的蛋白质降解的精确机制仍然是一个活跃的研究领域.
研究的目的:
- 开发能够诱导蛋白质降解并使药物同时成像的新型化水标签.
- 在卵巢癌细胞中研究这些与抗癌药物olaparib结合的新疗效标签的疗效,作用机制和强度.
- 通过蛋白质和成像技术阐明由theranostic标签激活的细胞反应和通路.
主要方法:
- 合成和表征的新的theranostic疏水标签.
- 将疏水性标签与olaparib结合在一起,用于向蛋白质降解.
- 在卵巢癌细胞中评估蛋白质降解效率 (DC50,Dmax) 和抗增殖活性 (IC50).
- 基于质谱的蛋白质组分析以确定细胞通路激活 (例如,UPR,ER压力,细胞周期).
- 刺激拉曼散射 (SRS) 显微镜用于成像细胞吸收和theranostic标签的定位.
主要成果:
- 化合物 (2c) 有效地降解了细胞内PARP-1的高强度 (DC50 = 0.618μM,Dmax = 55%).
- 与olaparib相比,2c化合物表现出显著增强的抗增殖活性 (IC50 = 62nM与11.52μM对比).
- 蛋白质组分析揭示了未折叠的蛋白质反应的激活,ER压力和细胞循环停止.
- SRS成像显示了ER和自的参与,在用药物合物治疗后.
结论:
- 开发的超性疏水标签是诱导向蛋白质降解并实现同时进行细胞成像的有效工具.
- 这些治疗药物显示出增强的抗癌功效,并为HyT诱导的蛋白质降解途径提供了新的机制性见解,包括ER和自的参与.
- 这项工作为开发具有内置成像能力的先进向蛋白质降解疗法开辟了新的途径.
相关概念视频
Tagging and Fusion Proteins
8.3K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
8.3K
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Regulated Protein Degradation
3.0K
3.0K
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K


